Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

POSS-based hybrid biomaterials for tissue engineering and regenerative medicine

Chen M., Wang Y., Wang M., Zhou W., Yu S., Lei B.

Narrative Review on Cartilage Damage, published in Mater Today Bio (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Mater Today Bio (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40487168
PMCID
PMC12144517
DOI
10.1016/j.mtbio.2025.101837
Citations
2

Abstract (original English)

Polyhedral oligomeric silsesquioxanes (POSS), as an organic-inorganic hybrid nanomaterial, have shown broad application prospects in biomedical field due to their unique rigid nano core structure and abundant modifiable functional groups. These characteristics make it an ideal platform for preparing POSS-based hybrid biomaterials (POSSHB) with controllable mechanical properties and tunable degradability. This article systematically elaborates on the preparation method, structural characteristics, and basic properties of POSSHB; The latest research progress of this type of material in the fields of bone and cartilage regeneration, wound repair, cardiovascular tissue engineering, nerve repair, dental restoration, ophthalmic treatment, and skeletal muscle regeneration is summarized, and the key role of POSSHB in tissue regeneration is deeply explored; Finally, future development directions and prospects are proposed in response to the limitations of current research.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research